Related Experiment Video

Updated: May 14, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Microglia in Epilepsy: From Molecular Mechanism to Therapeutic Strategy

Yam Nath Paudel1, Efthalia Angelopoulou2, Sai Kulkarni3

  • 1Department of Neurology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.

Cells
|May 13, 2026
PubMed

Insights

Microglia, the brain's immune cells, play a key role in epilepsy by causing neuroinflammation and neuronal death. Targeting microglia shows promise for new epilepsy treatments, reducing seizures in preclinical models.

Area of Science:

  • Neuroscience
  • Immunology
  • Epilepsy Research

Background:

  • Epilepsy treatment faces limitations, shifting focus to seizure-pathway understanding.
  • Microglia, the central nervous system's immune cells, are implicated in epilepsy pathogenesis.
  • Microglia contribute to seizures through neuroinflammation, neuronal death, and neurogenesis.

Purpose of the Study:

  • To review the multifaceted role of microglia in epilepsy.
  • To explore microglia's involvement in seizure-induced neuronal damage and neurogenesis.
  • To discuss therapeutic strategies targeting microglia for epilepsy.

Main Methods:

  • Review of existing literature on microglia and epilepsy.
  • Analysis of preclinical models investigating microglia depletion and modulation.
  • Examination of microglia-astrocyte interactions in epilepsy.

Main Results:

  • Microglia activation contributes to neuronal death and neurogenesis following seizures.
  • Pharmacological and genetic depletion of microglia reduces spontaneous recurrent seizures post-status epilepticus.
  • Targeting microglia demonstrates therapeutic potential in preclinical epilepsy models.

Conclusions:

  • Microglia are critical players in epilepsy development and progression.
  • Modulating microglial activity offers a promising therapeutic avenue for epilepsy.
  • Further research into microglia-based therapies could lead to novel disease-modifying treatments for epilepsy.
Keywords:
epilepsymicrogliamicroglia depletionminocyclineneurodegenerationneurogenesisseizure

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...